Concepedia
Publication | Open Access
A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
24
Citations
References
2022
Year
NCT04602000; 2020-003369-20 (EudraCT).
Page 1